Sorafenib Maintenance After Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia With <i>FLT3</i>–Internal Tandem Duplication Mutation (SORMAIN) - Concepedia

Concepedia

Publication | Open Access

Sorafenib Maintenance After Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia With <i>FLT3</i>–Internal Tandem Duplication Mutation (SORMAIN)

DOI Full Paper Access

538

Citations

40

References

2020

Year

Andreas Burchert, Gesine Bug, Lea Fritz, Jürgen Finke, Matthias Stelljes, Christoph Röllig, Ellen Wollmer, Ralph Wäsch, Martin Bornhäuser, Tobias Berg,

Journal of Clinical Oncology

Abstract

Sorafenib maintenance therapy reduces the risk of relapse and death after HCT for <i>FLT3-</i>ITD-positive AML.

References

	Year	Citations

Page 1